Latest News About Oppenheimer & Co. Inc.

Here’s the latest on Oppenheimer & Co. Inc. (OPY) based on recent public reports:

• Earnings and results: OPY reported strong results for 2025, with modest revenue growth across segments and a solid contribution from wealth management and capital markets activities. The firm also announced a special dividend and share repurchases in 2025. [sources indicate quarterly and annual figures as context, including a 2025 full-year result with notable profitability]

• Hiring and strategic moves: Oppenheimer has continued expanding its coverage, including adding senior hires in biotech and technology research to bolster its research platform, and has been active in expanding its private capital and healthcare sectors.

• Regulatory and litigation updates: There have been public disclosures about settlements related to legacy cash sweep programs, with settlements in the consent and escrow process under consideration by courts.

• Recent office and regional expansion: The firm has opened or announced expansion in multiple regional markets over the past couple of years, including Tennessee (Memphis) and other growth initiatives in wealth management and investment banking.

If you’d like, I can pull the most up-to-date articles and summarize key figures (revenue, earnings per share, AUM, dividends) with direct quotes and exact dates. I can also provide a quick one-page note with:

• Latest quarterly earnings snapshot
• Recent leadership or coverage changes
• Any material legal or regulatory developments
• Notable strategic initiatives (dividends, buybacks, regional expansions)

Would you like me to fetch and organize those details into a concise briefing?